£14.0M
The funding round was led by o2h Ventures Therapeutics Fund and supported by existing backers.
Metrion Biosciences
Metrion Biosciences provides specialist ion channel screening and drug discovery services.
£14.0MTotal raised
Metrion Biosciences is a specialist ion channel contract research organisation and drug discovery business. The firm provides customers with access to a range of high quality assays and screening services.
Categories
Team
Keith McCullagh
Chairman
Keith serves as chairman at Metrion Biosciences and Xention. He has previously held non-executive chairmanships and directorships across several life sciences and healthcare companies.
LinkedInKO
Katie Odgaard